Evidence map›Paper›PMID 41395571›Full record

ArticleInternational cancer conference journal2025

Transanal minimally invasive surgery for rectal gastrointestinal stromal tumor using articulated forceps after neoadjuvant chemotherapy with imatinib mesylate.

Hideyuki Masui, Yoshiro Itatani, Ryosuke Okamura, Michio Okamoto, Atsushi Yamada, Yusuke Sakamoto, Nobuaki Hoshino, Koya Hida, Kazutaka Obama

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hideyuki MasuiDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-0771-540X
Yoshiro ItataniDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-7356-7065
Ryosuke OkamuraDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Michio OkamotoDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Atsushi YamadaClinical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yusuke SakamotoDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Nobuaki HoshinoDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Koya HidaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-7210-7075
Kazutaka ObamaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0003-2924-6701

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rectal gastrointestinal stromal tumors (GISTs) are rare, accounting for approximately 5% of all GISTs and 0.1% of all rectal malignancies. Radical resection without capsule violation is the standard treatment for localized GISTs. However, surgical resection of large rectal GISTs poses challenges because of the narrow pelvic anatomy and the need to preserve excretory function. Based on KIT mutation status, neoadjuvant imatinib therapy facilitates tumor shrinkage and improves surgical outcomes. A 72-year-old man presented with dyschezia and hematochezia. Colonoscopy revealed a submucosal rectal tumor measuring 3 cm from the anal verge, which was diagnosed as a GIST based on biopsy findings (c-kit and DOG1 positive). Imaging studies confirmed the presence of a 5-cm tumor with significant Supplementary Information: The online version contains supplementary material available at 10.1007/s13691-025-00786-7.

Indexed as

Articulating forcepsGastrointestinal stromal tumorImatinibNeoadjuvant therapyTransanal minimally invasive surgery

Identifiers

PMID41395571
PMCPMC12696246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.